← Research library

The use of prostatilen in treating patients with prostatic diseases

Observational study · 1991

What was studied
37 patients with chronic prostatitis and 15 with prostatic adenoma
Main finding
Describes changes in symptoms, urinary measures and reproductive-function measures with Prostatilen.

Reported findings and study design

Prostatilen clinical report: 37 patients with chronic prostatitis and 15 with prostatic adenoma.

Population or model 37 patients with chronic prostatitis and 15 with prostatic adenoma

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Symptoms, uroflow and semen measuresChanges reportedNumerical outcome values and comparator data absent
Adverse reactionsNone reported in this small study

Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Small mixed clinical groups; control methods and adverse-event ascertainment unclear from the abstract.
  • The tissue extract is not the synthetic peptide Prostamax.

Source details

Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.

Sources checked

Citation

Uncontrolled human reportEnglish abstract

Vozianov AF, Gorpinchenko II, Boĭko NI, Drannik GN, Khavinson VKh. The use of prostatilen in treating patients with prostatic diseases Urol Nefrol (Mosk) (6):43-46. PMID 1823683

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards